BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+29.04%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$514M
AUM Growth
+$514M
Cap. Flow
-$62.2M
Cap. Flow %
-12.1%
Top 10 Hldgs %
73.17%
Holding
39
New
7
Increased
8
Reduced
6
Closed
8

Top Buys

1
FWP
Forward Pharma A/S American Depositary Shares
FWP
$21.9M
2
XENE icon
Xenon Pharmaceuticals
XENE
$12.2M
3
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
$8.11M
4
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
$8M
5
CASC
Cascadian Therapeutics, Inc.
CASC
$7.4M

Top Sells

1
RCPT
RECEPTOS INC COM STK (DE)
RCPT
$71.2M
2
FPRX
Five Prime Therapeutics, Inc.
FPRX
$17.2M
3
LGND icon
Ligand Pharmaceuticals
LGND
$13.2M
4
ARRY
Array Biopharma Inc
ARRY
$9.95M
5
PRQR icon
ProQR Therapeutics
PRQR
$9.44M

Sector Composition

1 Healthcare 70.58%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IRWD icon
1
Ironwood Pharmaceuticals
IRWD
$214M
$78M 15.18% 5,093,810 -503,255 -9% -$7.71M
CCXI
2
DELISTED
ChemoCentryx, Inc.
CCXI
$58.7M 11.42% 8,596,772 – –
ARRY
3
DELISTED
Array Biopharma Inc
ARRY
$55.7M 10.83% 11,772,335 -2,104,178 -15% -$9.95M
LGND icon
4
Ligand Pharmaceuticals
LGND
$3.15B
$45.8M 8.9% 860,063 -248,700 -22% -$13.2M
OMED
5
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$29.9M 5.82% 1,374,815 +86,968 +7% +$1.89M
CASC
6
DELISTED
Cascadian Therapeutics, Inc.
CASC
$26.1M 5.09% 13,762,260 +3,894,982 +39% +$7.4M
FPRX
7
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$22.3M 4.34% 826,332 -635,568 -43% -$17.2M
FWP
8
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$21.9M 4.26% +1,052,381 New +$21.9M
CYTK icon
9
Cytokinetics
CYTK
$4.23B
$19.6M 3.81% 2,443,100 +916,100 +60% +$7.34M
GYRE icon
10
Gyre Therapeutics
GYRE
$703M
$17.5M 3.4% 6,655,128 – –
CNCE
11
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$16.1M 3.13% 1,206,459 – –
LOXO
12
DELISTED
Loxo Oncology, Inc
LOXO
$14M 2.72% 1,190,702 -1,500 -0.1% -$17.6K
VTAE
13
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$12.5M 2.44% 753,935 +87,935 +13% +$1.46M
XENE icon
14
Xenon Pharmaceuticals
XENE
$2.98B
$12.2M 2.38% +618,224 New +$12.2M
QLTI
15
DELISTED
QLT Inc
QLTI
$10.6M 2.07% 2,650,563 +557,000 +27% +$2.23M
ONCT
16
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$8.11M 1.58% +11,111,111 New +$8.11M
VIRX
17
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$8M 1.56% +3,136,000 New +$8M
EXEL icon
18
Exelixis
EXEL
$10.1B
$6.04M 1.18% +4,195,352 New +$6.04M
ARQL
19
DELISTED
Arqule Inc
ARQL
$5.76M 1.12% 4,723,811 +422,924 +10% +$516K
SVRA icon
20
Savara
SVRA
$567M
$4.08M 0.79% +7,291,600 New +$4.08M
ACHV icon
21
Achieve Life Sciences
ACHV
$152M
$3.13M 0.61% 1,368,500 +706,431 +107% +$1.62M
BLRX
22
BioLineRX
BLRX
$16.2M
$2.43M 0.47% 1,501,000 – –
KBIO
23
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$2.01M 0.39% 1,162,000 – –
AKAO
24
DELISTED
Achaogen, Inc.
AKAO
$1.78M 0.35% 136,600 – –
TBRA
25
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$1.72M 0.33% 1,882,521 -724,570 -28% -$662K
1
2